DIABETES Flashcards

1
Q

What is the difference between type 1 and type 2 diabetes?

A

Type 1: insulin deficiency due to immune mediate destruction of insulin producing pancreatic beta cells
Type 2: relative insulin deficiency caused by progressive loss of pancreatic beta cell insulin secretion on background of insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the BSL range for “pre-diabetes”?

A

fasting: 6.1 - 6.9 mmol/L

random/OGTT: 7.8 - 11 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the diagnostic HbA1c and BSL for diabetes?

A

Fasting BSL > 7
Random BSL >11
HbA1c > 6.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When should HbA1c be checked post partum?

A

Not within the first 3 months post partum as it will be falsely low due to lower BSL concentrations due to pregnancy (haemodilution).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the procedure of an OGTT`

A
  • Fast overnight for 8-12 hours, avoid smoking or caffiene
  • take fasting blood sample before 75g glucose drink
  • drink must be consumed within 5 min
  • pt must remain seated and not eat or drink for the 2 hour duration of test
  • if non pregnant take blood test at 2 hours after consuming the drink, if pregnant take blood at 1 hour and 2 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Screening for T2DM

A
  • AUSDRISK: should be used every 3 years in > 40s or > 18 if ATSI
  • considers: age, sex, ethnicity, fhx, elevated BP, elevated BSL, smoking, diet, physical activity and obesity
  • if at high risk screening should be annual
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What AUSDRISK score = high, intermediate or low risk

A
Low = 5 and under
Intermediate = 6-11
High = > 12
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 5 goals of diabetes management?

A
  1. optimise quality of life
  2. manage hyperglycaemia
  3. avoid acute complications (DKA, HONK)
  4. avoid hypoglycaemia
  5. avoid chronic complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What should be included in a diabetes management plan?

A
  • short and long term goals and treatment targets
  • dietary plan
  • physical activity and exercise plan
  • medication management plan
  • sick day management plan
  • schedule for screening and monitoring of complications
  • ways to reduce cardiovascular disease
  • plan for self management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What classifies as severe hyperglycaemia?

A

BSL > 20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indications for referral to hospital in adults with hyperglycaemia

A
  • signs of ketosis
  • signs of dehydration
  • severe hyperglycaemia and vomiting
  • symptoms and signs of underlying infection
  • altered LOC, confusion or delirium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 3 insulin regimens for Type 1 diabetes?

A
  1. multiple daily injections (basal + bolus), usually 4 injections daily
  2. continuous s/c insulin infusion via pump
  3. mixed insulin, usually 2 injections daily
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What BSL and HbA1c targets should Type 1 diabetics have?

A

BSL 4-8

HbA1c < 7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Examples of total daily insulin doses at different phases and ages.

A
  • during remission phase for all ages—less than 0.5 units/kg daily
  • beyond remission phase for pre-adolescent children—0.7 to 1 unit/kg daily
  • beyond remission phase during puberty—1.2 to 1.5 units/kg daily.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the aim of basal insulin in T1DM?

A
  • aim to lower rates of nocturnal hypoglycaemia

- aim to achieve fasting BSL 4-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How often should children with T1DM check their BSL?

A

At least four times a day, before meals and at bedtime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is LADA?

A

Latent autoimmune diabetes

  • T1DM subtype
  • associated with type 1 autoantibodies (GAD and IA-2 _ ZnT8)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What BSL targets should be given to adult patients with T1DM?

A

Fasting BSL 4-8

Post prandial BSL 6-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What percentage of total daily insulin should basal insulin be?

A

~40-50% of total daily insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name 3 long acting insulins and their onset/peak and duration

A

Detemir 100 units/ml: onset 90min, duration 16-24hrs
> levemir

Glargin 100 units/ml: onset 1-2 hours, duration up to 24H
> lantus

Glargin 300 units/ml: onset 1-6 hrs, duration 24-36hrs
> toujeo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Name 4 rapid acting insulins

A
  1. Aspart 100units/ml (Novorapid)
    > onset 10-15min, peak 60-90min, duration 3-5 hrs
  2. Glulisine 100 units/ml (Apidra)
    > onset 10-15 min, peak 60-90 min, duration 3-5 hrs
  3. Lispro 100 units/ml (Humalog)
    > onset 10-15min, peak 1-2 hours, duration 3-5 hrs
  4. Lispro 200unit/ml (Humalog U200)
    > onset 10-15min, peak 1-2 hours, duration 3-5 hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the general onset, peak and duration of rapid acting insulins?

A

Novorapid, apidra, humalog

Onset - 10-15min
Peak - 1-2 hrs
Duration - 3-5 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Name 1 short acting insulin.

A

Neutral 100 unit/ml (Actrapid, Humulin)

> onset 30min, peak 2-3 hours, duration 6-7 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the total daily insulin requirement for a healthy adult?

A

0.5-0.8 units/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What is the typical initial total daily insulin dose for a type 1 diabetics?
0.3-0.4 units/kg
26
What is the most common insulin regimen for type 1 diabetes?
``` Basal = 40% daily or BD, long acting insulin Bolus = 60% in divided doses 15 min prior to meals, rapid or short acting insulin ```
27
Describe how to adjust basal insulin.
Dose of basal insulin should be adjusted by 10-20% every 3-7 days until fasting BSL targets (4-8) are achieved. Should always stabilise basal insulin first before adjusting bolus doses.
28
Describe how to adjust bolus insulin.
Provided patient is having fixed carbohydrate intake bolus insulin doses can be adjusted by 10-20% every 3-7 days to achieve: > 2 hour post prandial bsl * * most patients will have an insulin:carbohydrate i. e. 1:10, if eating 60g of carbs will need 6 units of insulin
29
Correction/supplemental insulin doses
1. This is calculated by drop in BSL concentration from a 1 unit bolus 2. If patient is on a stable insulin dose you can calculate from total daily insulin > sensitivity factor = 100/total daily insulin dose Example = total daily insulin dose 50U, needing to drop BSL from 14 to 6 (8mmol/L drop). > sensitivity factor = 100/50 = 2, therefore 1 unit of insulin will drop BSL by 2 > hence correction dose needed will be 4 units Given in combination to usual dose of bolus to cover carbohydrate content of meal
30
How to avoid hypoglycaemia with exercise in T1DM.
- eat 15-30g of carb for every 30 min of moderate exercise - reduce insulin dose in relation to anticipated intensity and duration - if aerobic exercise expected to last more than 30 min a decreased insulin dose is preferred to increased carb intake
31
When should ketones be tested for in T1DM?
- during acute illness or stress - when BSLs are consistently > 15 - with symptoms of DKA, nausea/vomiting/abdo pain
32
What classified as mild ketosis?
ketones 0.6-1.5mmol/L | > 1.5 indicates potential for developing DKA
33
How often should HbA1c be reviewed in T1DM?
Every 3-4 months
34
How often should retinopathy be screened for in T1DM?
- start screening 2-5 years after diagnosis (after 11) - assess every 12 months if ATSI, known retinopathy, high HbA1c levels Otherwise assess every 2 years if previous eye examination was normal
35
How often should a foot examination/peripheral neuropathy be screened for in T1DM?
If high risks screening every 3-4 months | Otherwise at least annually
36
Other autoimmune screening in T1DM.
Thyroid: every 2 years Coeliac: screen at 2 and 5 years after diagnosis
37
How often should lipids be screened for in T1DM?
- every 5 years if normal results
38
Describe effects of alcohol and hypoglycaemia.
ETOH inhibits glucose production by the liver and increases risk of hypoglycaemia in T1DM
39
T1DM and driving
- bsl should always be checked prior to driving to ensure it is > 5 - bsl should be checked Q2H while driving - patients should always have glucose containing foods available while driving
40
Metformin role in pre-diabetes.
- metformin has greatest benefits in reducing progression to diabetes in adults < 60 with BMI > 35 - should consider if lifestyle modifications are unsuccessful
41
What are the glycaemic targets in T2DM?
- < 7% generally - however can be more aggressive in newly diagnosed patients - <6% if lifestyle modifictaion +/- metformin - <6.5% if 2 antihyperglycaemics
42
Physical activity recommendations in T2DM
- 150 -300min per week of moderate intensity exercise | - interrupt sitting every 30 minutes
43
Indications for bariatric surgery
- T2DM + BMI > 40 or with BMI 35-40 in context of suboptimal glycaemic control despite optimal lifestyle modifications and medical treatment
44
Dietary advice for T2DM
- aim for 5-10% weight loss - suggest low GI food: wholegrain bread, pasta, fruits and dairy provides - reduce sugar!
45
Factors influencing choice of antihyperglycaemic agent in T2DM
Patient factors - degree of hyperglycaemia - risk of hypoglycaemia - weight - comorbidities Drug factors - efficacy - potential nonglycaemic effects (i.e. CVD benefit) - risk of hypoglycaemia - effect on patient weight - contraindications
46
Anti-hyperglycaemic class: Biguanide | Advantages and Disadvantages
Metformin - MOA: suppresses glucose production by liver and increases insulin sensitivity Advantages: unlikely to cause hypoglycaemia, assist with weight loss, improved cardiovasc outcomes, low cost Disadvantages: GIT side effects, B12 deficiency, lactic acidosis (rare) Renal: adjust dose in renal impairment
47
Anti-hyperglycaemic class: Sulfonylureas | Advantages and Disadvantages
Gliclazide, glipizide, glibenclamide MOA: act at the pancreas to stimulate insulin secretion Advantages: low cost Disadvantage: can cause weight gain and hypoglycaemia, especially in older patients Renal: avoid in patients with renal impairment!
48
Anti-hyperglycaemic class: DPP4I | Advantages and Disadvantages
"Gliptins" - sitagliptin, linagliptin, saxagliptin MOA: inhibits breaks down of GLP1 leading to increase insulin secretion and reduce glucagon Advantages: hypoglycaemia unlikely, no weight gain, improves post prandial glucose control, safe in patients with CVD (except saxagliptin) Disadvantage: avoid in heart failure, avoid in pts with hx of pancreatitis, can cause MSK pain Renal: reduce dose with renal impairment
49
Anti-hyperglycaemic class: GLP1 RA | Advantages and Disadvantages
"Tides" - guaglutide, exenatide, liraglutide MOA: increases insulin secretion and reduced glucagon secretion by inhibiting action of DPP4 by binding GPL1 Advantages: hypoglycaemia unlikely, weight loss, improves post prandial bsl, reduces CVD events, slows progression of CKD Disadvantages: avoid in patients with hx of pancreatitis or family hx of thyroid ca or MEN, GIT side effects Renal: avoid in severe renal impairment
50
Anti-hyperglycaemic class: SGLT2 I | Advantages and Disadvantages
"Flozins" MOA: increases glucose excretion in urine Advantages: hypoglycaemia unlikely, weight loss, reduces CVD risk, reduces BP, slows progression of CKD Disadvantages: avoid in fasting pts due to risk of euglycaemic DKA, can cause urinary infections, reversible increase in creatinine Renal: reduced glycaemic efficacy with renal impairment
51
What medication is suggested for T2DM patients with HbA1c < 8.5% at diagnosis?
Metformin immediately OR after 2-3 months if targets not achieved with lifestyle modification Second drug: sulfonulurea, DPP4 or SGLT2 inhibitor If CVD risk factors: consider SGLT2 inhibitor of GLP 1 If target not achieved in 3 months add or substitute a third drug: sulfonylurea, DPP4, SGLT2I or GLP1 RA
52
What medication is suggested for T2DM patients with HbA1c > 8.5% at diagnosis?
Start metformin and a second drug immediately
53
Suggested management if on triple antihyperglycaemic rx in T2DM and still not achieving glycaemic control.
- if using triple therapy change one or more drugs to GLP1 receptor agonist OR insulin - if using a regimen with a GLP1R agonist change this to a basal insulin OR add a basal or mixed insulin regimen - if using a basal insulin consider adding SGLT2I or GLP1 RA - or may need to consider basal + multipole daily injections (basal- bolus) or BD mixed insulin regimen
54
Initial insulin dosing in T2DM with suboptimal control
Long acting insulin 0.2 units/kg (up to 30units) S/C daily
55
What is the pathophys behind hyperglycaemia in acute illness in diabetics?
Counter-regulatory hormones such as glucagon, cortisol and adrenaline
56
Sick day plan for T1DM
- check BSL + ketones every 1-4 hours - ketones > 0.6 + high BSL suggests need for supplemental insulin and increased fluids - in acute illness basal insulin requirement generally increases and supplemental/correction rapid acting insulin should be given every 2-4 hours in addition to usual meal time boluses to reduce hyperglycaemia and stop ketosis
57
Sick day plan for T2DM
- if unwell and BSL > 12 mmol/l without episodes of hypoglycaemia can increase basal insulin by 10-20% (110-120% of usual insulin dose) - may need to include short term rapid acting boluses doses with meals to manage acute hyperglycaemia - metformin may need to be withheld if dehydrated or reduced renal function - SGLT2 inhibitors should be withheld! - GLP1 RA can be temporarily withheld if nausea, vomiting or anorexia - DPP4I can be continued - sulfonylureas can be continued as tolerated
58
With what renal function is metformin contraindicated?
Creat clearance < 40ml/min | CKD stage III or more
59
Which antihyperglycaemic agent is associated with increased risk of UTI and DKA?
SGLT2 inhibitors
60
What antihyperglycaemic agent is contraindicated in heart failure?
DPP4 inhibitor "gliptin"
61
What is the cut off for HbA1c for major elective procedures?
<9%
62
Suggested subcut insulin management day of procedure in T1DM.
Morning procedure: normal basal insulin, omit rapid acting insulin, hourly BSLs from waking Afternoon procedure: normal basal insulin, given half usually rapid acting bolus, withhold lunch rapid insulin
63
Pre-procedural insulin infusion
Run with 5% glucose at 100ml/hr Run insulin units/hr based on patients total daily insulin dose and their BSL (measured hourly) Run between 1-4units/hour if normal BSL
64
Acute vs chronic (micro/macro) complications of diabetes (3 in each)
Acute: hypoglycaemia, HONK, DKA Microvascular: kidney disease, retinopathy, neuropathy Macrovascular: CAD, PVD, stroke
65
Management of severe hypoglycaemia: adult
- severe: unable to be self managed by patient - glucagon 1mg IM/SC - IV glucose: 10% 150-200ml (15-20g) over 15 min OR IV glucose 20% 75-100ml (15-20g) over 15 min Once conscious need to give long acting complex carb
66
Management of severe hypoglycaemia: child
- glucagon: <25kg = 0.5mg IM/SC, >25kg = 1mg IM/SC - IV glucose 10%: 1-2 ml/kg over 20 min until BSL >4 DO not give 50% dextrose to children due to risk of hyperosmolality and death
67
Products containing 15g of glucose
``` 15g tube of glucose gel 6-7 jelly beans or 4 large glucose jelly beans 3 teaspoons honey or sugar 125ml of fruit juice 150ml of soft drink ```
68
Management of non-severe hypoglycaemia
- when patient is able to self correct orally Child: 5-10g glucose PO Adult: 15g glucose PO * if BLS < 3 in adults given at leat 20g glucose Rule of 15s - 15g glucose, recheck in 15 min
69
Which antihyperglycamic has greatest risk of hypoglycaemia?
Sulfonylureas due to stimulation of insulin secretion - gliclazide, glipizide, glibenclamide Especially prominent if only insulin
70
Characteristics of DKA
- dehydration - hyperglycaemia - polyuria, polydipsia, tachypnoea - acetone breath - nausea/vomiting/abdo pain
71
Typical blood gas results in DKA
pH <7,3 bicarb <15 ketones > 1.5 BSL > 14 (but can be lower if taking SGLT2I)
72
Describe management of mild ketosis
Ketones 0.6 - 1.5 | Can be managed as per sick day management plan withe extra insulin
73
What are the 4 main aims of management of DKA?
1. correction of fluid loss with aggressive rehydration 2. correction of hyperglycaemia and suppression of ketone production with insulin > with addition of glucose infusion once BSL drops 3. correction of electrolytes - especially potassium 4. investigation of precipitant/cause
74
Which has a higher mortality HONK or DKA?
HONK!
75
Definition of HONK
- high serum osmolality: often >320 - extreme hyperglycaemia > 30 - severe dehydration
76
How to calculate effective serum osmolality
2 x (Na + K) + BSL + urea concentration Should be calculated hourly Aim for reduction of 3mmol/kg/hours and can titrate fluids to these
77
Aims of HONK management
- slow and safe replacement of IV fluids and electrolytes - slowly and safely normalise BSL - treat underlying cause - wait to avoid rapid correction of effective serum osmolality
78
What are the estimated fluid losses in HONK?
100-200ml/kg | Treat with 50% of estimated fluids loss within first 12 hours and then the remainder over 12-36 hours
79
Use of insulin in HONK
- if ketones are <1 can hold off on insulin until after some rehydration as this will reduce BSL - once BSL stops falling from rehydration reassess fluid intake, renal function and can start IV insulin infusion - start at 0.05units/kg/hour - aim to reduce BSL by 4-6 mmol/L with target of 10-15mmol/L Less commonly but if ketone > 1 then start insulin concurrently with IV rehydration
80
Define normal, micro and macro albuminuria
Women: 3.5, 3.5-35, > 35 Men: 2.5, 2.5-25, >25
81
Stages of CKD by GFR
``` I. >90 II 60-89 IIIa 45-59 IIIb 30 - 44 IV. 15-29 V < 15 ```
82
Which antihyperglycaemic medications slow progression of diabetic kidney disease?
SGLT2I | Liraglutide
83
What cholesterol medication can slow progression of diabetic retinopathy?
Fenofibrate | Can slow progression irrespective of blood lipid level
84
Management of painful diabetic neuropathy
1. amitriptyline 25mg nocte Need to exclude other causes i..e B12 deficiency and myeloma
85
Charcot arthropathy
- unilateral, red, hot swollen foot - destructive joint disorder caused by diabetes - associated with peripheral neuropathy - causes inflammation leading to bone fracture, dislocation, instability - if suspected need to place patient NWB
86
Features of diabetic autonomic neuropathy
- hypoglycaemia unawareness - erectile dysfunction - orthostatic hypotension - diabetic gastroparesis - diarrhoea - bladder atony and urinary retention - cardiac autonomic neuropathy
87
Pharmacological management of orthostatic hypotension in diabetic autonomic neuropathy
Fludocortisone 100mcg daily, increasing according to response to max 300 mcg daily
88
BP target in diabetes
<130/80 with albuminuria/proteinuria Otherwise <140/90 First line management ACEI/ARB Likely will require CCB or thiazide in addition for combination approach
89
Diabetes and aspirin
Not recommended for primary prevention of CVD however advised if known atherosclerosis
90
When should OGTT be repeated post partum in women with GDM?
At 6-12 weeks post partum but can be delayed until 4-6 months post partum if not practical
91
What vaccinations are recommended for diabetics?
Influenza Pneumococcus DTPA